arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Scholar Rock Holding Corp

SRRK
$52.94 ▲ +0.25 (+0.46%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

Scholar Rock Holding Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.1B
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -88.0%
FCF / Share $-2.62
Trailing P/E
Price / Book 23.4x
FCF Yield
Debt / Equity 0.41
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-377.94M
↓ -53.5%
Operating Margin Operating profit as % of sales
-404.8%
↓ -52.1%
FCF / Share Free cash flow per share
$-2.62
↓ -30.2%
Long-Term Debt Long-term obligations
$99.71M
↑ +98.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
4
Financial Health
36
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters